摘要
目的探讨妊娠期妇女年龄、孕周、甲状腺过氧化物酶抗体与促甲状腺激素(TSH)水平的相关性;建立TSH和游离甲状腺素(FT4)二维复合参考区间,探讨其在诊断妊娠期亚临床甲状腺功能减退症(SCH)的适用性。方法选择2016年1月至2017年7月在四川省妇幼保健院进行产前检查的人群中,符合纳入标准的健康妊娠妇女2 556例,检测空腹血清TSH、FT4及甲状腺过氧化物酶抗体(TPO-Ab)水平。分别将妊娠早、中、晚期TSH和FT4经过正态转换,得到TSH和FT4的Skewness系数和Kurtosis系数。用以上系数根据Mahalanobis距离原理建立二维复合参考区间公式。结果①妊娠期妇女TSH水平与FT4呈负相关(r=-0.305,P<0.001),与TPO-Ab呈正相关(r=0.255,P<0.001);②以传统参考区间作为诊断标准,诊断SCH 190例,TPO-Ab阳性组诊断出43例;以二维复合参考区间作为诊断标准,诊断SCH 44例;TPO-Ab阳性组诊断出20例。结论基于妊娠期妇女TSH和FT4水平建立的二维复合参考区间可能更适于诊断SCH,能减少误判风险,使疾病诊断趋于精准。
Objective To detective the correlation of thyroid stimulation hormone(TSH) level with age, gestational week and thyroid peroxidase antibodies(TPO-Ab) in pregnant women, and to establish composite reference intervals for TSH and free thyroxine(FT4) and their effect in diagnosis of subclinical hypothyroidism(SCH).Methods From January 2016 to July 2017, 2 556 healthy pregnant women from those taking prenatal checkup in Sichuan Provincial Hospital for Women and Children were recruited. Their serum levels of TSH,FT4 and TPO-Ab were determined. The serum TSH and FT4 data in the first, second and third trimester were transformed into normal distributions, with outliers being eliminated and a correction for skewness and kurtosis. The composite reference intervals were established according to the Mahalonobis distance formula. Results Serum TSH was negatively correlated with FT4(r=-0.305,P<0.001) but positively correlated with TPO-Ab(r=0.255,P<0.001). Using conventional reference standards,190 participants were identified with SCH, which included 43 showing TPO-Ab positive. In contrast, using composite reference intervals, 44 participants were identified with SCH, which included 20 showing TPO-Ab positive. Conclusion The composite reference intervals based on TSH and FT4 may lead to a better definition of SCH with fewer false positives. It could make the diagnosis of the disease more precise.
引文
[1]Koehler V F, Reincke M, Spitzweg C.Hypothyroidism-when and how to treat?[J].Internist(Berl),2019,60(1):108.
[2]孔德华,孙颖,黄玮,等.不同妊娠期孕妇甲状腺激素水平的检验分析[J].国际检验医学杂志,2016,37(20):2889-2891.
[3]Alexander E K, Pearce E N, Brent G A, et al.2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J].Thyroid,2017,27(3):315–389.
[4]Springer D, Jiskra J, Limanova Z, et al.Thyroid in pregnancy:from physiology to screening[J].Critical Reviews in Clinical Laboratory Sciences,2017,54(2):102-116.
[5]Maraka S, Singh Ospina N M, Mastorakos G, et al.Subclinical hypothyroidism in women planning conception and during pregnancy:who should Be treated and how?[J].J Endocr Soc,2018,2(6):533-546.
[6]江东.不同孕期孕妇甲状腺激素水平变化及其与TPO-Ab的关系研究[J].国际检验医学杂志,2017,38(9):1286-1287.
[7]卢雪玲,阿丽娅·吉力力,王宁.乌鲁木齐市汉族孕妇甲状腺功能与碘营养状态的相关性[J].中华临床营养杂志,2018,26(2):83-89.
[8]Zhang Yixin, Du Cong, Wang Wei, et al.Effect of maternal and neonatal factors on neonatal thyroid stimulating hormone:results from a population-based prospective cohort study in China[J].J Trace Elem Med Biol,2018,49:151-156.
[9]王文美,余晓敏.孕早、中期甲状腺功能减退与年龄因素的相关性分析[J].中国妇幼健康研究,2015,26(3):499-500.